Literature DB >> 25521833

FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms.

Tomohiro Mita1, Masato Furuhashi, Shinya Hiramitsu, Junnichi Ishii, Kyoko Hoshina, Shutaro Ishimura, Takahiro Fuseya, Yuki Watanabe, Marenao Tanaka, Kohei Ohno, Hiroshi Akasaka, Hirofumi Ohnishi, Hideaki Yoshida, Shigeyuki Saitoh, Kazuaki Shimamoto, Tetsuji Miura.   

Abstract

OBJECTIVE: Fatty acid-binding protein 4 (FABP4) is expressed in adipocytes, and elevated plasma FABP4 level is associated with obesity-mediated metabolic phenotype. Postprandial regulation and secretory signaling of FABP4 has been investigated.
METHODS: Time courses of FABP4 levels were examined during an oral glucose tolerance test (OGTT; n=53) or a high-fat test meal eating (n=35). Effects of activators and inhibitors of adenyl cyclase (AC)-protein kinase A (PKA) signaling and guanylyl cyclase (GC)-protein kinase G (PKG) signaling on FABP4 secretion from mouse 3T3-L1 adipocytes were investigated.
RESULTS: FABP4 level significantly declined after the OGTT or a high-fat meal eating, while insulin level was increased. Treatment with low and high glucose concentration or palmitate for 2 h did not affect FABP4 secretion from 3T3-L1 adipocytes. FABP4 secretion was increased by stimulation of lipolysis using isoproterenol, a β3 -adrenoceptor agonist (CL316243), forskolin, dibutyryl-cAMP and atrial natriuretic peptide, and the induced FABP4 secretion was suppressed by insulin or an inhibitor of PKA (H-89), PKG (KT5823) or hormone sensitive lipase (CAY10499).
CONCLUSIONS: FABP4 is secreted from adipocytes in association with lipolysis regulated by AC-PKA- and GC-PKG-mediated signal pathways. Plasma FABP4 level declines postprandially, and suppression of FABP4 secretion by insulin-induced anti-lipolytic signaling may be involved in this decline in FABP4 level.
© 2014 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25521833     DOI: 10.1002/oby.20954

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  44 in total

Review 1.  Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics.

Authors:  Alexander Yang; Emilio P Mottillo
Journal:  Biochem J       Date:  2020-03-13       Impact factor: 3.857

2.  Unconventional Secretion of Adipocyte Fatty Acid Binding Protein 4 Is Mediated By Autophagic Proteins in a Sirtuin-1-Dependent Manner.

Authors:  Ajeetha Josephrajan; Ann V Hertzel; Ellie K Bohm; Michael W McBurney; Shin-Ichiro Imai; Douglas G Mashek; Do-Hyung Kim; David A Bernlohr
Journal:  Diabetes       Date:  2019-06-06       Impact factor: 9.461

3.  Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus.

Authors:  Masato Furuhashi; Shinya Hiramitsu; Tomohiro Mita; Takahiro Fuseya; Shutaro Ishimura; Akina Omori; Megumi Matsumoto; Yuki Watanabe; Kyoko Hoshina; Marenao Tanaka; Norihito Moniwa; Hideaki Yoshida; Junnichi Ishii; Tetsuji Miura
Journal:  J Lipid Res       Date:  2015-10-14       Impact factor: 5.922

4.  Differential modulation of cytosolic lipases activities in liver and adipose tissue by high-carbohydrate diets.

Authors:  Angélica Heringer Rodrigues; Carolina Campos Lima Moreira; Érica Guilhen Mario; Letícia Maria de Souza Cordeiro; Gleide Fernandes Avelar; Leida Maria Botion; Valéria Ernestânia Chaves
Journal:  Endocrine       Date:  2016-02-13       Impact factor: 3.633

5.  Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension.

Authors:  Masato Furuhashi; Tomohiro Mita; Norihito Moniwa; Kyoko Hoshina; Shutaro Ishimura; Takahiro Fuseya; Yuki Watanabe; Hideaki Yoshida; Kazuaki Shimamoto; Tetsuji Miura
Journal:  Hypertens Res       Date:  2015-02-12       Impact factor: 3.872

6.  Mechanisms of Artemisia scoparia's Anti-Inflammatory Activity in Cultured Adipocytes, Macrophages, and Pancreatic β-Cells.

Authors:  Anik Boudreau; Susan J Burke; J Jason Collier; Allison J Richard; David M Ribnicky; Jacqueline M Stephens
Journal:  Obesity (Silver Spring)       Date:  2020-08-02       Impact factor: 5.002

Review 7.  Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment.

Authors:  Meric Erikci Ertunc; Gökhan S Hotamisligil
Journal:  J Lipid Res       Date:  2016-06-21       Impact factor: 5.922

8.  FABP4 regulates eosinophil recruitment and activation in allergic airway inflammation.

Authors:  Xiao Na Ge; Idil Bastan; Mythili Dileepan; Yana Greenberg; Sung Gil Ha; Kaylee A Steen; David A Bernlohr; Savita P Rao; P Sriramarao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-04-26       Impact factor: 5.464

9.  Exogenous FABP4 interferes with differentiation, promotes lipolysis and inflammation in adipocytes.

Authors:  Hui-Xia Dou; Ting Wang; Hai-Xia Su; Ding-Ding Gao; Ye-Chun Xu; Ying-Xia Li; He-Yao Wang
Journal:  Endocrine       Date:  2019-12-16       Impact factor: 3.633

10.  Fatty Acid-Binding Protein 4 (FABP4) Is Associated with Cartilage Thickness in End-Stage Knee Osteoarthritis.

Authors:  Paul Schadler; Birgit Lohberger; Bettina Thauerer; Martin Faschingbauer; Werner Kullich; Martin Helmut Stradner; Rusmir Husic; Andreas Leithner; Bibiane Steinecker-Frohnwieser
Journal:  Cartilage       Date:  2021-07-05       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.